Adverse events624

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 624

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Pancytopenia	Blood and lymphatic system disorders	Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection	0	7	0
other	Pancytopenia	Blood and lymphatic system disorders	Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection	0	7	0
other	Pancytopenia	Blood and lymphatic system disorders	Group 2: Sotatercept 0.2 mg/kg IV Injection	1	9	1
other	Pancytopenia	Blood and lymphatic system disorders	Group 2: Sotatercept 0.26 mg/kg SC Injection	0	9	0
other	Pancytopenia	Blood and lymphatic system disorders	Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection	0	12	0
other	Pancytopenia	Blood and lymphatic system disorders	Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection	0	6	0
other	Angina pectoris	Cardiac disorders	Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection	1	7	1
other	Angina pectoris	Cardiac disorders	Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection	0	7	0
other	Angina pectoris	Cardiac disorders	Group 2: Sotatercept 0.2 mg/kg IV Injection	0	9	0
other	Angina pectoris	Cardiac disorders	Group 2: Sotatercept 0.26 mg/kg SC Injection	0	9	0
other	Angina pectoris	Cardiac disorders	Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection	0	12	0
other	Angina pectoris	Cardiac disorders	Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection	0	6	0
other	Atrial fibrillation	Cardiac disorders	Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection	1	7	2
other	Atrial fibrillation	Cardiac disorders	Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection	0	7	0
other	Atrial fibrillation	Cardiac disorders	Group 2: Sotatercept 0.2 mg/kg IV Injection	0	9	0
other	Atrial fibrillation	Cardiac disorders	Group 2: Sotatercept 0.26 mg/kg SC Injection	0	9	0
other	Atrial fibrillation	Cardiac disorders	Group 3: Sotatercept 0.1 - 0.4 mg/kg IV Injection	0	12	0
other	Atrial fibrillation	Cardiac disorders	Group 3: Sotatercept 0.4 - 0.5 mg/kg SC Injection	0	6	0
other	Hyperparathyroidism	Endocrine disorders	Group 1: Sotatercept 0.1 mg/kg Intravenous (IV) Injection	0	7	0
other	Hyperparathyroidism	Endocrine disorders	Group 1: Sotatercept 0.13 mg/kg Subcutaneous (SC) Injection	0	7	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01999582/events

API reference For AI assistants

Adverse events624

Sources 3

Read this list from software.